Back to search
FDAFDA · Food and drugs·Recall number D-018-2014

Alprazolam Orally Disintegrating Tablets, USP 2 mg, 100 count bottles, Rx Only, MFG. BY ACTAVIS ELIZABETH LLC., Elizabeth, NJ, NDC 0228-4025-11

Published December 4, 2013 · Recall initiated: October 9, 2013

Summary

FDA records drug Class II recall D-018-2014, published December 4, 2013 and initiated October 9, 2013. Recalling firm: Actavis Elizabeth LLC; Status: Terminated; Reported quantity: 756 bottles; Lot: Lot # 59380831, Exp. May 2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification in some tablets

What to do

Voluntary: Firm initiated · Letter

Get an email if ALPRAZOLAM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ALPRAZOLAM
Manufacturer
Actavis Elizabeth LLC
Distributor
Nationwide
Lot
Lot # 59380831, Exp. May 2014
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Alprazolam Orally Disintegrating Tablets, USP 2 mg, 100 count bottles, Rx Only, MFG. BY ACTAVIS ELIZABETH LLC., Elizabeth, NJ, NDC 0228-4025-11 recalled?

Yes. FDA published recall D-018-2014 on December 4, 2013. Reported hazard: Failed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification in some tablets

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ALPRAZOLAM.